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Abstract: Objective:  To identify the risk factors identified within one month post-stroke that
predict the onset of post-stroke shoulder pain (PSSP) within the first year after stroke.
Methods:  Five databases, (AMED, CINAHL, EMBASE, Medline, PubMed) were
searched from inception to April 2019. Prospective cohort studies that measured a
potential risk factor for post-stroke shoulder pain within the first month after stroke were
included. Two authors independently reviewed and selected articles for inclusion. Risk
of bias was assessed using the Quality in Prognosis Studies tool. Data extracted
included raw data for odds ratio (OR) calculations, definition and measurement of pain,
study limitations and baseline characteristics of participants. The review was
conducted following PRISMA guidelines.
Results:  Nine articles were retrieved that met the inclusion criteria, and six presented
data to use in meta-analysis. Fifty-four different factors were identified as potential risk
factors. Meta-analysis was possible for four factors; sex (OR 0.93, CI 0.75-1.15),
laterality (OR 0.78, CI 0.59-1.05), diabetes (OR 2.09, CI 1.16-3.78), and history of
shoulder pain (OR 2.78, CI 1.29-5.97). Reduced motor function in the upper limb was
also identified as a significant risk factor through qualitative synthesis.
Conclusions:  Reduced motor function in the upper limb, diabetes, and a history of
shoulder pain were identified as significant risk factors for the development of PSSP
within the first year after stroke. Recommendations to standardise future studies in this
area have been made and it is suggested that defining subtypes of PSSP may aid
future interventional studies.
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Dear Prof Biller: 
 
Thank you for the opportunity to resubmit our manuscript entitled “Risk Factors for Post-Stroke Shoulder 
Pain: A Systematic Review and Meta-analysis” for consideration. We are again grateful to the reviewers 
for taking the time to reconsider our revisions.  
 
We appreciate the reviewer’s comments regarding the improved clarity the revisions have made. There 
was a further revision recommended: 
 
Please add that correlates of PSSP were beyond the scope of this paper and include as a limitation in the 
Discussion. 
 
We are grateful for the reviewer’s comment and have added the recommended statement ‘consequently 
correlates of PSSP were beyond the scope of this study’ on line 105. However, given that we have made a 
number of references in the text as to why correlates were not included in the current study, we feel it 
would confuse the reader to say we then considered this lack of inclusion a limitation of the study. As our 
aim in the study was ‘to identify the potential risk factors measured within the first month after stroke that 
predicted the onset of shoulder pain within the first year after stroke’ we feel the inclusion of correlates 
would confound the results. We have therefore not added this to the limitation section.  
 
We hope that the amendment is sufficient and that our justification for not including in the limitations 
section is clear. The revised manuscript has been appended and we have highlighted the revision on line 
105 in yellow. 
 






Rich Holmes, MSc MCSP 
Extended Scope Physiotherapist 
Western Sussex Hospitals NHS Trust 
Cover letter / Response to Reviewers
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Objective: To identify the risk factors identified within one month post-stroke that 5 
predict the onset of post-stroke shoulder pain (PSSP) within the first year after 6 
stroke.  7 
Methods: Five databases, (AMED, CINAHL, EMBASE, Medline, PubMed) were 8 
searched from inception to April 2019. Prospective cohort studies that measured a 9 
potential risk factor for post-stroke shoulder pain within the first month after stroke 10 
were included. Two authors independently reviewed and selected articles for 11 
inclusion. Risk of bias was assessed using the Quality in Prognosis Studies tool. 12 
Data extracted included raw data for odds ratio (OR) calculations, definition and 13 
measurement of pain, study limitations and baseline characteristics of participants. 14 
The review was conducted following PRISMA guidelines. 15 
Results: Nine articles were retrieved that met the inclusion criteria, and six 16 
presented data to use in meta-analysis. Fifty-four different factors were identified as 17 
potential risk factors. Meta-analysis was possible for four factors; sex (OR 0.93, CI 18 
0.75-1.15), laterality (OR 0.78, CI 0.59-1.05), diabetes (OR 2.09, CI 1.16-3.78), and 19 
history of shoulder pain (OR 2.78, CI 1.29-5.97). Reduced motor function in the 20 
upper limb was also identified as a significant risk factor through qualitative 21 
synthesis. 22 




Conclusions: Reduced motor function in the upper limb, diabetes, and a history of 23 
shoulder pain were identified as significant risk factors for the development of PSSP 24 
within the first year after stroke. Recommendations to standardise future studies in 25 
this area have been made and it is suggested that defining subtypes of PSSP may 26 




Post-stroke shoulder pain (PSSP) is a common and often debilitating consequence 29 
of stroke. Wide variations of incidence have been reported in the literature 30 
dependent on the patient cohort and methodology used. Most recent studies have 31 
found an incidence rate of between 18-22% at 3-4 months after stroke onset1-3 with a 32 
slight reduction at 1 year post-stroke to between 6-21%.3,4 Lindgren et al2 reported 33 
that 73% of patients with PSSP reported they had pain daily whilst a further 11% 34 
reported constant pain, and 45% required some form of analgesic medication. 35 
 36 
PSSP is known to negatively impact on a person’s ability to carry out activities of 37 
daily living, such as walking and dressing,2 and limit their ability to participate in 38 
leisure activities.5 Furthermore it has been shown to be associated with reduced 39 
quality of life6,7 as well as having a direct impact on mood.5 Barlak et al8 also 40 
reported a significantly longer stay in rehabilitation for patients with PSSP.  41 
 42 
There is therefore a need to limit the impact of this common consequence of stroke 43 
through robust prevention strategies and effective treatment modalities. However, 44 
difficulties arise due to the complex and multifactorial nature of PSSP.9 A large 45 
variety of possible aetiologies are described in the literature including 46 
musculoskeletal disorders such as rotator cuff dysfunction, bursitis, adhesive 47 
capsulitis, and impingement, as well as neurogenic problems such as spasticity, 48 
central hypersensitivity and complex regional pain syndrome.10 Unsurprisingly this 49 
multitude of aetiologies has led to multiple interventions been suggested in the 50 
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literature. However, there seems to be little consensus on the implementation of 51 
some of these interventions11-13 making assessment of their effectiveness difficult. A 52 
review by Li and Alexander14 supported this when they found the evidence for 53 
treatments of PSSP to be lacking, though this should not be misinterpreted as 54 
evidence that treatments are ineffective. 55 
 56 
The lack of consensus on best management makes prevention all the more 57 
important. However, to prevent PSSP we must first understand which patients are 58 
most at risk so that strategies can be put in place and regular assessments can be 59 
done to monitor any early developments of PSSP and limit the impact in the chronic 60 
stages. To answer this question, a number of often cited studies have explored 61 
factors that are correlated with PSSP such as subluxation,15 spasticity,16 and 62 
abnormal joint examination.17 But due to the lack of repeated temporal measures 63 
these correlations do not show causation and the factors explored should not be 64 
interpreted as risk factors.  65 
 66 
To date, reviews exploring PSSP have either been narrative in nature18 or have 67 
focussed on factors that are correlated with PSSP.19 Whilst these give an indication 68 
of factors closely linked to PSSP, they are limited by the variations in methodologies 69 
included and do not give a satisfactory answer to the matter of risk.  70 
 71 
There is, therefore, a need to collate those studies investigating specifically risk and 72 
predictive factors that are effectively assessed and quantified using robust 73 
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prospective studies to see if there is agreement within the literature. The aim of this 74 
systematic review was to identify the potential risk factors measured within the first 75 





To complete and report this review the Preferred Reporting Items for Systematic 81 
Reviews and Meta-Analyses (PRISMA) statement20 was used. 82 
 83 
Search Strategy 84 
The search strategy was designed with the aid of a clinical librarian with input from 85 
the two lead authors (RH/KM). The databases AMED (1985 – April 2019), CINAHL 86 
(1937 – April 2019), EMBASE (1974 – April 2019), Medline (1946 – April 2019), and 87 
PubMed were used with no limitations applied. Variants of ‘stroke’, ‘shoulder pain’, 88 
and ‘risk factors’ were used as keywords and combined in the search strategy. The 89 
full search strategy can be viewed on the International Prospective Register of 90 
Systematic Reviews (PROSPERO: CRD42018110406) where this systematic review 91 
was registered. Further articles were sourced by hand-searching through the 92 
reference lists of key articles. The websites www.clinicaltrials.gov and 93 
www.ukctg.nihr.ac.uk were regularly reviewed to check for any ongoing trials that 94 




Study Selection 97 
Studies were eligible for inclusion only if the following three criteria were present: a) 98 
they were prospective cohort studies, b) they measured any potential risk factor 99 
within the first month after stroke and c) they measured pain as a key outcome within 100 
one year after stroke. Any definition and measure of pain used by study authors was 101 
deemed acceptable for inclusion. Studies in languages other than English were 102 
included only if a full-text English version could be sourced. To answer the specific 103 
question of risk it was felt essential that there was an element of temporality between 104 
the measurement of the risk factor and the measurement of pain, consequently 105 
correlates of PSSP were beyond the scope of this study. Studies were therefore 106 
excluded if they were cross-sectional studies in which all measures were taken at a 107 
single time-point (thereby assessing correlation rather than risk). Case reports, 108 
conference abstracts, poster presentations or other studies where the full report was 109 
not available were also excluded. 110 
 111 
Two reviewers (RH and KM) screened the titles and abstracts independently. Full-112 
text versions of the selected papers were obtained and were assessed against the 113 
inclusion and exclusion criteria by the same reviewers, again independently. Where 114 
there was disagreement a consensus was made through discussion along with the 115 




Authors were contacted when articles were lacking sufficient detail to assess the 118 
inclusion criteria. In all cases clarity was sought to understand if baseline measures 119 
were recorded within the first month after stroke. Authors were asked at what point 120 
baseline measures were taken and, to avoid bias, were not given information of the 121 
research question or the inclusion criteria.  122 
 123 
Data extraction & risk of bias assessment 124 
The main data extracted included all factors that were identified and analysed as 125 
potential risks or where sufficient data were supplied for factors where an odds ratio 126 
(OR) could be calculated. Other data extracted included the aims and methodology 127 
of each study, the period of observation, baseline characteristics of the cohort, 128 
inclusion/exclusion criteria, how pain was defined and measured, the temporal 129 
aspect of baseline and repeated measures, and limitations of the study in relation to 130 
the research question. 131 
 132 
The risk of bias of included studies was independently assessed by two reviewers 133 
(RH and KM) using the Quality in Prognosis Studies (QUIPS) tool.21 This tool 134 
considers six domains (Study Participation, Study Attrition, Prognostic Factor 135 
Measurement, Outcome Measurement, Study Confounding, and Statistical Analysis 136 
and Reporting) and rates these as having low, moderate or high risk of bias. Any 137 
disagreement between reviewers related to these assessments was resolved 138 




The overall risk of bias was determined a priori and judged as: low if 4 or more of the 141 
domains were rated low and no domains rated as high, moderate if 4 or less 142 
domains were rated low with one domain rated as high or 3 or less domains rated as 143 
low with no high risk domains, and high if 2 or more domains were rated as high or if 144 
1 domain was rated as high with no low risk domains. 145 
 146 
Data Synthesis 147 
The articles were described and summarised in a narrative form. Where possible, 148 
raw data were extracted from the original papers to calculate ORs and 95% 149 
confidence intervals (CI) with the intention of pooling these outcomes in meta-150 
analysis. Where raw data were not available the ORs presented in the original 151 
articles were used. 152 
 153 
Attempts were made to perform meta-analysis when data for a dichotomous variable 154 
were presented in three or more studies. Between-study heterogeneity was 155 
evaluated at face value based on methodological characteristics such as inclusion 156 
criteria and the method of outcome measurement. If there was substantial variation 157 
in the methods used then data were interpreted narratively. When it was possible to 158 
combine data, heterogeneity was assessed using the I2 statistic, although it is 159 
acknowledged that detecting true heterogeneity with a very small number of studies 160 




All analyses were performed using random effects models to account for the varied 163 
approaches within the studies. Funnel plots to assess for publication bias were not 164 
presented as it was felt that the small number of studies included would limit their 165 
usefulness of this analysis. All analyses were undertaken using the software 166 




Literature Search 171 
The search from the selected databases returned a total of 1,077 articles (figure 1). 172 
An additional 31 articles were sourced through hand-searching reference lists from 173 
key articles (n=3) and through search alerts following the initial search (n=28). During 174 
screening 593 were excluded as they clearly did not meet the necessary inclusion 175 
criteria. A further 11 abstracts were discarded as they were found to be poster 176 
presentations or conference abstracts, and one final paper published in Spanish23 177 
was excluded as it was not possible to access in English. 178 
 179 
The full text of the remaining 30 articles were assessed in more detail. A further 21 180 
were excluded due to (a) risk factors not been measured within the first month after 181 
stroke,8,17,24-30 (b) exploring factors correlated with PSSP rather than risk,15,16,31-36 (c) 182 
retrospective methodologies,37,38 and (d) studies’ aims not exploring risk of 183 
PSSP.39,40 Authors of four articles were contacted to seek further clarification 184 
regarding the timing of baseline measures. For two of these studies41,42 the authors 185 
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were able to confirm that the baseline measures were recorded within the first month 186 
and were included in the review. Of the other two, one author was unable to recall17 187 
and one author did not respond.8 These were therefore excluded. 188 
 189 
Figure 1. PRISMA Flow diagram of study selection 190 
<insert Figure 1> 191 
 192 
The remaining nine2,3,41-47 articles were included in the systematic review. Of these, 193 
seven provided sufficient data to calculate ORs on the four risk factors that had 194 
sufficient data to conduct meta-analyses. However, the study by Isaksson et al43 was 195 
excluded from all meta-analyses as it was thought to be too heterogeneous due to 196 
only including patients with pronounced UL weakness. It was felt that this was a 197 
significant difference from the populations of the other studies and was likely to 198 
significantly skew the analysis. 199 
 200 
Characteristics of included studies 201 
The nine papers included consisted of eight prospective cohort studies from seven 202 
different countries published between 200344 and 2018.41 A summary of the 203 
characteristics of the included studies is presented in table 1. The mean sample size 204 
of the studies was 309 (range: 31-1474). In total 2474 patients were included in the 205 
data synthesis consisting of 1237 (50%) males and 1237 (50%) females. It was not 206 
possible to calculate a combined description of participants’ age due to the variation 207 
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in descriptive statistics provided across studies. Three studies2,3,45 reported types of 208 
stroke and found that 87% (n=566) patients had an ischaemic stroke. Side of stroke 209 
was reported in four studies3,45-47; 54% (n=247) of participants having a left 210 
hemispheric stroke and 46% (n=211) having a right hemispheric stroke. 211 
 212 
Table 1. Characteristics of included studies 213 
<insert Table 1> 214 
 215 
Three papers2,3,44 included all stroke patients and took steps to ensure that 216 
participants with communication or cognitive impairments were included by involving 217 
carers or next-of-kin. One paper43 restricted participants to only those with 218 
pronounced arm weakness limiting the comparability with other studies. Another47 219 
explored only patients who had persistent PSSP leading to the loss of two patients 220 
who had pain but were excluded from the final analysis. 221 
 222 
Five studies2,3,44,46,47 presented prevalence rates or provided sufficient data to 223 
calculate a rate for PSSP at specific time points. Two studies did not present clear 224 
enough data to calculate a true prevalence, and one study looked at a specific 225 
subsection of patients. At baseline (within the first week), data was available on 1672 226 
patients3,44 and gave a prevalence rate of 16%. This prevalence increased to 21% 227 
(103/483) at four months,2,3 24% (293/1235) at 6 months44,47 and 23% (105/453) at 228 




The nine papers presented data on a total of 54 different factors that were measured 231 
temporally to allow the calculation of risk. Within these, seven were categorised as 232 
Demographic factors, 13 as Co-morbidities, and 34 as Clinical assessments and 233 
measures (table 1). 234 
 235 
Pain Measurement 236 
There were large variations in how pain was defined and measured. Four papers 237 
defined pain as either at rest or during passive or active movement43,45-47 but none of 238 
these reported how the data was handled when conflicting results between ‘at rest’ 239 
and ‘on movement’ were found. Four papers did not specify how they defined 240 
PSSP,2,41,42,44 and a final paper defined PSSP as any subjective complaint in the 241 
hemiplegic shoulder.3 Six papers used either the Visual Analogue Scale2,3,41,42 or the 242 
Numeric Rating Scale45,47 but only two42,45 reported a cut-off value to signify who had 243 
and did not have pain. The other three studies43,44,46 simply reported whether pain 244 
was ‘present’ or ‘absent’ to group their cohorts. Four studies assessed for pain using 245 
only subjective reports,2,43-45 whilst the others combined clinical examination and 246 
history-taking to determine if pain was present. 247 
 248 
Risk of Bias 249 
The risk of bias was assessed using the QUIPS tool and the ratings for each 250 
individual domain can be seen in figure 2. The level of agreement between the two 251 
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assessors (RH and KM) was calculated using the weighted Cohen’s kappa statistic 252 
(weighted κ = 0.68) which corresponded to a substantial degree of agreement.48 253 
 254 
Using these domains and a priori determined criteria, two studies2,3 were judged to 255 
have an overall low risk of bias, five studies to be moderate risk of bias,42-45,47 and 256 
two studies41,46 to have a high risk of bias overall.  257 
 258 
Figure 2. Assessment of risk of bias using the Quality in Prognosis Studies tool 259 
<insert Figure 2> 260 
 261 
Meta-analysis 262 
Only four factors had sufficient data to enable meta-analysis. All analyses were 263 
conducted using a random effects model to account for variations in the approaches 264 
used and samples taken. 265 
 266 
Five studies were included in the analysis of sex. Meta-analysis showed that there 267 
was no difference in the odds for men and women developing PSSP (OR 0.93, CI 268 
95% 0.75-1.15, p=0.501) (figure 3). The I2 statistic was very low (0.13%) suggesting 269 
heterogeneity was not present. However, Kontopantelis et al22 suggest caution when 270 
I2 is so low as it is likely that heterogeneity is present but undetected. Indeed the 271 





Four studies were included in the analysis of stroke laterality. Again no statistical 275 
difference was found in relation to whether the stroke was in the right or left 276 
hemisphere (OR 0.78, CI 95% 0.59-1.05, p=0.097, I2=9.52%) (figure 4). 277 
Interestingly, although not statistically significant, there is a shift of the 95% CI 278 
towards patients with right hemisphere strokes having a slightly increased risk of 279 
PSSP. Further studies would be needed to explore this. 280 
 281 
Figure 3. Forest plot displaying the pooled OR analysis for sex  282 
<insert Figure 3> 283 
 284 
Figure 4. Forest plot displaying the pooled OR analysis for laterality  285 
<insert Figure 4> 286 
 287 
The analysis for diabetes included six studies. Meta-analysis showed that diabetic 288 
patients were twice as likely to develop PSSP as patients without diabetes (OR 2.09, 289 
95% CI 1.16-3.78) and that this finding was statistically significant (p=0.015). 290 
However, there was a high degree of statistical heterogeneity (I2=74.15%) as can be 291 




Only three studies were available to conduct a meta-analysis for history of shoulder 294 
pain thereby limiting the acceptability of the results. The analysis identified that a 295 
history of shoulder pain increased the risk of developing PSSP (OR 2.78, 95% CI 296 
1.29-5.97) which was significant (p=0.009). Again, as can be seen in figure 6, there 297 
was a high level of heterogeneity between studies although an I2 statistic was not 298 
calculated as it was felt displaying this with the small number of included studies 299 
would provide misleading or inaccurate information. It is also worth noting that two 300 
studies with data were excluded from analysis due to significant variations in their 301 
inclusion criteria. Isaksson et al43 only included patients with pronounced weakness, 302 
and Roosink et al47 excluded patients with severe pre-morbid pain. Notably both of 303 
these studies showed non-significant results (table 3). 304 
 305 
All other factors were not appropriate for combining in meta-analysis and are 306 
summarised in narrative synthesis below. 307 
 308 
Figure 5. Forest plot displaying the pooled OR analysis for diabetes  309 
<insert Figure 5> 310 
 311 
Figure 6. Forest plot displaying the pooled OR analysis for history of shoulder pain 312 





The data for demographic data can be viewed in table 2. Analyses for age as a risk 316 
factor were inconclusive due the variations in measurement used. One study45 317 
reported an increased risk for younger patients (<70 years). However, two other 318 
studies3,44 found age to be nonsignificant as a predictor of PSSP when used as a 319 
factor in multivariate analysis. 320 
 321 
Four papers reported data on the type of stroke. Isaksson et al43 reported data that 322 
showed patients with haemorrhagic strokes were more likely to develop PSSP, 323 
however only patients with pronounced weakness were included which could bias 324 
the result. The other three studies2,3,45 showed no significant difference between 325 
types of stroke as a predictor. 326 
 327 
It was possible to calculate ORs for the subtype of stroke (Oxfordshire classification) 328 
in two papers.2,3 Only the total anterior circulation stroke was shown to be a 329 
significant risk for developing PSSP at four months when compared with lacunar 330 
stokes. 331 
 332 
One paper42 considered smoking habits as a potential risk factor but data was not 333 
available to calculate an OR. 334 
 335 
Table 2. Demographics - Factors with sufficient data to calculate OR 336 





Diabetes and a history of shoulder pain has been discussed in the meta-analysis. Of 340 
the other co-morbidities with data available for ORs none showed a statistically 341 
significant increased odds of developing PSSP (table 3). Temporary 342 
unconsciousness at onset was considered as a risk factor in one paper42 but data 343 
was not available to calculate an OR.  344 
 345 
Table 3. Comorbidities - Factors with sufficient data to calculate OR 346 
<insert Table 3> 347 
 348 
Clinical assessments and measures 349 
The full list of measures and ORs for clinical assessment and measures can be seen 350 
in table 4. Severity of upper limb (UL) motor function was concluded to be a major 351 
risk factor in four papers.2,3,44,45 Unfortunately a variety of outcome measures was 352 
used making comparisons unfeasible. Significant results were found for the odds 353 
ratio of a poor score on item 5 on the National Institutes of Health Stroke Scale (≥3) 354 
for the development of pain within 6 months45 and within 1 year.3 This measure was 355 
also shown to be significant (p=0.03) in a logistic regression analysis by Lind et al2 356 




Kim et al45 also measured motor function using the Fugl-Meyer arm score and found 359 
those patients with lower motor function (a score of 20 or less) were statistically 360 
more likely to develop PSSP at 6 months post-stroke than those with higher scores. 361 
 362 
Ratnasabapathy et al44 reported an increasing risk of PSSP as UL motor deficit 363 
increased from mild to moderate to severe, suggesting a potential trend. However it 364 
is worth noting that these categories were subjective reports from study participants 365 
and not based on standardised measures. 366 
 367 
It was deemed inappropriate to combine the findings for UL motor function in a meta-368 
analysis due to the substantial heterogeneity in the method of measurement. 369 
However, an impairment in UL motor function at baseline consistently produced a 370 
significantly increased chance of developing PSSP leading to the conclusion that it 371 
was an important risk factor to be aware of. 372 
 373 
Adey-Wakeling et al3 considered a specific set of shoulder tests (namely the 374 
modified Neer’s test, passive hand-behind-neck, and passive external rotation 375 
compared with the unaffected limb) as originally described by Rajaratnam et al.36 376 
Despite finding that these tests were able to identify a higher frequency of PSSP 377 
than by patient-report, when included in a multivariate analysis the odds ratio was 378 
not significant. This was supported by 2 other studies45,47 who explored early 379 





Table 4. Clinical assessments and measures - Factors with sufficient data to 383 
calculate OR 384 
<insert Table 4> 385 
 386 
Aspects of somatosensory function including sensation to light touch, sensation to 387 
temperature, sharpness, proprioception, tactile inattention and tactile extinction were 388 
also explored. Only tactile extinction and proprioception were found to significantly 389 
increase the risk of developing PSSP. 390 
 391 
Kim et al45 presented data on various baseline radiological and sonographic findings 392 
(table 1). Readers are directed to the original article to see the full list of ORs for the 393 
factors explored as they are too extensive to be repeated here. Only tendinosis or 394 
tear of the supraspinatus tendon at baseline sonography was associated with PSSP 395 
onset within the first 6 months (OR 4.21, 95% CI 1.37-12.93). 396 
 397 
Data was available to calculate ORs for PSSP at baseline in 2 studies,3,44 and found 398 
conflicting results. Paci et al46 did not provide data to calculate an OR but did find 399 
pain at baseline to be significantly associated with pain at follow-up in their multiple 400 
regression analysis (p<0.001), though this was approximately 2 to 3 months after 401 




Across the included studies, it was possible to calculate ORs for a number of other 404 
baseline measures including motor impairment, stroke severity, spasticity in the UL, 405 
subluxation of the glenohumeral joint, dependency during gait, cognition, visual 406 
problems, and autonomic function (table 4). These factors were each reported in 407 
only one study and the majority showed no significant relationship to the onset of 408 
PSSP. Only motor impairment (measured using the Motricity Index) and subluxation 409 
showed significant results though the wide 95% CIs for these results would bring into 410 
question the precision of this result.  411 
 412 
Anxiety, depression, communication disorders, and motivation for rehabilitation were 413 




This systematic review has identified reduced motor function in the UL, diabetes, and 418 
a history of shoulder pain as risk factors for the development of PSSP within the first 419 
year after stroke. It has also identified a number of clinical assessments made in the 420 
acute stages of stroke that were statistically significant but were only measured in 421 
single studies and lack the benefit of confirmatory evidence. These factors were 422 





The results presented should be interpreted with caution. Care was taken to limit 426 
bias as much as possible by only including prospective studies and by undertaking a 427 
complete and thorough literature search. However, meta-analyses of observational 428 
studies are prone to the biases inherent in the original studies,49 and unfortunately, 429 
the majority of studies included in this review were rated as a moderate or high risk 430 
of bias. Because of this potential bias, as much of the raw data as was feasible was 431 
included to increase transparency. This was also done so that the reader could make 432 
their own conclusions regarding the weighting each study had on the level of risk for 433 
each factor.   434 
 435 
The likelihood that reduced motor function in the UL leads to an increased risk of 436 
PSSP is unsurprising. The loss of motor function will undoubtedly alter the kinetics 437 
and kinematics around the shoulder complex. This suboptimal performance of 438 
scapula kinesis and the reduced control of forces around the humeral head on the 439 
glenoid has the potential to lead to deleterious effects on anatomical structures 440 
around the shoulder.50 Indeed, Idowu et al51 found a significantly higher frequency of 441 
shoulder pathologies in hemiplegic shoulders when compared with unaffected 442 
shoulders and control subjects, whilst Yi et al52 found a trend towards a higher 443 
prevalence of rotator cuff tears with worsening hemiplegia. Unfortunately, neither of 444 
these studies correlated these sonographic findings with the incidence of pain. 445 
 446 
A more recent prospective study53 of 121 participants further confirmed the 447 
association of reduced motor function of the UL as a risk factor for PSSP. They also 448 
concluded, in support of Paci et al,46 that subluxation was an important risk factor 449 
22 
 
and reported a significant proportional difference between those with subluxation 450 
who did and did not have PSSP at the 8-10 week follow up (p=0.026). However, 451 
when the data are used to calculate an OR in the same method as this review the 452 
outcome is non-significant (OR 1.68, 95% CI 0.49-5.70). It would seem logical that 453 
subluxation of the glenohumeral joint would lead to similar pathobiomechanics as 454 
previously discussed and thereby also be a risk factor for PSSP. However, further 455 
confirmatory studies with a temporal element to the measurement of risk factors and 456 
pain are required to clarify this. 457 
 458 
The identification of diabetes as a risk factor for PSSP is also unsurprising given the 459 
increased prevalence of shoulder pain in diabetic patients in the general 460 
population.50 Both tendinopathy51 and adhesive capsulitis52 were found to be more 461 
prevalent in patients with diabetes and both of these conditions are a potential 462 
source of PSSP. The increased risk of shoulder pain in diabetic patients is thought to 463 
be due to advanced glycation end-products causing stiffness and weakness in 464 
connective tissues,53 this, coupled with the reduced function following a stroke, may 465 
further enhance the damaging effects of structures in the shoulder complex. 466 
 467 
This exploratory review has identified a number of factors from the best available 468 
evidence that may aid clinicians in the early identification of patients who may 469 
develop PSSP. Based on these results it is advised that clinicians ensure they 470 
routinely enquire about diabetes and any history of shoulder pain when taking a 471 
patient’s medical history. It is not recommended that these findings should be 472 
construed as definitive due to the limitations mentioned hereinafter, however they 473 
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should be used as a guide to aid clinical reasoning and decision-making when 474 
deciding on which patients to focus preventative strategies. Knowledge of these risk 475 
factors may aid in the understanding of causation and thereby lead to more targeted 476 
prevention strategies. They will also provide clinicians with prognostic information to 477 
better inform patients, carers and relatives. 478 
 479 
Study Limitations  480 
There were a number of limitations within this systematic review that will impact on 481 
the validity of these results. These limitations were to be expected given the complex 482 
nature of PSSP observed in a clinical setting. Firstly, there were large variations in 483 
the included studies with regards to how pain was defined, how and when risk 484 
factors were measured, and how data were analysed. This has made comparability 485 
between studies very challenging and whilst some data have been combined in 486 
meta-analysis the results should be viewed as informative rather than definitive due 487 
to the heterogeneous nature of the studies included. 488 
 489 
Secondly, due to the large number of potential factors measured, the included 490 
studies may have been limited in what could feasibly be reported, potentially causing 491 
under-reporting or selective reporting of certain variables. Attempts were made to 492 
overcome this potential bias by calculating ORs for all factors where possible, 493 
thereby allowing the recognition of certain risk factors not reported or considered in 494 
the original studies. Whilst calculating crude ORs in this way allowed a larger pool of 495 
data it is recognised that univariate analysis of this type does not take into account 496 
the impact these different factors have on each other thereby potentially leading to 497 





The current categorisation of PSSP within the literature presents a potential problem. 501 
Whilst it is well documented that PSSP is complex and multifactorial in nature it is 502 
often referred to as a single entity rather than as an umbrella-term for a number of 503 
different aetiologies. This broad definition of PSSP is potentially limiting the 504 
specificity of research trials leading to conflicting results. It is recommended that 505 
future studies should explore improved classification of PSSP subtypes to allow 506 
more accurate links to be made between risk factors and PSSP presentation. 507 
 508 
It is also recommended that future studies exploring risk have a standardised and 509 
comparable approach to the measurement of pain. Whilst it is acknowledged that the 510 
measurement of pain in stroke patients presents some difficulties with regards to 511 
validity and reliability,58 a vertical numeric rating scale would be the preferred option. 512 
It is also recommended that data for pain at rest and on passive or active movement 513 
is analysed and reported separately to improve comparability. Studies exploring 514 
factors associated with PSSP should also give consideration to, and report on, any 515 
qualitative differences in the nature and pattern of pain between subjects, as well as 516 
factors such as whether the pain was at night or on clinical assessment only. 517 
Observational studies of this nature may help to better understand PSSP subtypes 518 
and improve specificity. Where possible, efforts should be made to ensure the 519 
inclusion of patients with communication or cognitive difficulties by using carers as 520 




Motor impairment of the upper limb was repeatedly shown to increase the risk of 523 
PSSP, however it was not possible to combine in meta-analysis due to variation in 524 
measurement. This important factor warrants further investigation. In this review the 525 
Fugl-Meyer Assessment was the most credible of the outcome measures used and 526 





This review has identified motor deficits in the UL, diabetes and a history of shoulder 532 
pain to be significant predictors of the development of PSSP within the first year after 533 
stroke. Whilst it is acknowledged that the lack of robust studies included prevent 534 
definitive conclusions to be made, it is hoped that the results presented will provide 535 
clinicians with a potential ‘at risk’ group of patients in the acute stage of stroke on 536 
whom to focus preventative strategies. A number of recommendations to standardise 537 
future studies in this area have been made. Future observational studies defining 538 
and categorising the subtypes of PSSP would be beneficial to aid research into the 539 
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Objective: To identify the risk factors identified within one month post-stroke that 5 
predict the onset of post-stroke shoulder pain (PSSP) within the first year after 6 
stroke.  7 
Methods: Five databases, (AMED, CINAHL, EMBASE, Medline, PubMed) were 8 
searched from inception to April 2019. Prospective cohort studies that measured a 9 
potential risk factor for post-stroke shoulder pain within the first month after stroke 10 
were included. Two authors independently reviewed and selected articles for 11 
inclusion. Risk of bias was assessed using the Quality in Prognosis Studies tool. 12 
Data extracted included raw data for odds ratio (OR) calculations, definition and 13 
measurement of pain, study limitations and baseline characteristics of participants. 14 
The review was conducted following PRISMA guidelines. 15 
Results: Nine articles were retrieved that met the inclusion criteria, and six 16 
presented data to use in meta-analysis. Fifty-four different factors were identified as 17 
potential risk factors. Meta-analysis was possible for four factors; sex (OR 0.93, CI 18 
0.75-1.15), laterality (OR 0.78, CI 0.59-1.05), diabetes (OR 2.09, CI 1.16-3.78), and 19 
history of shoulder pain (OR 2.78, CI 1.29-5.97). Reduced motor function in the 20 
upper limb was also identified as a significant risk factor through qualitative 21 
synthesis. 22 
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Conclusions: Reduced motor function in the upper limb, diabetes, and a history of 23 
shoulder pain were identified as significant risk factors for the development of PSSP 24 
within the first year after stroke. Recommendations to standardise future studies in 25 
this area have been made and it is suggested that defining subtypes of PSSP may 26 




Post-stroke shoulder pain (PSSP) is a common and often debilitating consequence 29 
of stroke. Wide variations of incidence have been reported in the literature 30 
dependent on the patient cohort and methodology used. Most recent studies have 31 
found an incidence rate of between 18-22% at 3-4 months after stroke onset1-3 with a 32 
slight reduction at 1 year post-stroke to between 6-21%.3,4 Lindgren et al2 reported 33 
that 73% of patients with PSSP reported they had pain daily whilst a further 11% 34 
reported constant pain, and 45% required some form of analgesic medication. 35 
 36 
PSSP is known to negatively impact on a person’s ability to carry out activities of 37 
daily living, such as walking and dressing,2 and limit their ability to participate in 38 
leisure activities.5 Furthermore it has been shown to be associated with reduced 39 
quality of life6,7 as well as having a direct impact on mood.5 Barlak et al8 also 40 
reported a significantly longer stay in rehabilitation for patients with PSSP.  41 
 42 
There is therefore a need to limit the impact of this common consequence of stroke 43 
through robust prevention strategies and effective treatment modalities. However, 44 
difficulties arise due to the complex and multifactorial nature of PSSP.9 A large 45 
variety of possible aetiologies are described in the literature including 46 
musculoskeletal disorders such as rotator cuff dysfunction, bursitis, adhesive 47 
capsulitis, and impingement, as well as neurogenic problems such as spasticity, 48 
central hypersensitivity and complex regional pain syndrome.10 Unsurprisingly this 49 
multitude of aetiologies has led to multiple interventions been suggested in the 50 
4 
 
literature. However, there seems to be little consensus on the implementation of 51 
some of these interventions11-13 making assessment of their effectiveness difficult. A 52 
review by Li and Alexander14 supported this when they found the evidence for 53 
treatments of PSSP to be lacking, though this should not be misinterpreted as 54 
evidence that treatments are ineffective. 55 
 56 
The lack of consensus on best management makes prevention all the more 57 
important. However, to prevent PSSP we must first understand which patients are 58 
most at risk so that strategies can be put in place and regular assessments can be 59 
done to monitor any early developments of PSSP and limit the impact in the chronic 60 
stages. To answer this question, a number of often cited studies have explored 61 
factors that are correlated with PSSP such as subluxation,15 spasticity,16 and 62 
abnormal joint examination.17 But due to the lack of repeated temporal measures 63 
these correlations do not show causation and the factors explored should not be 64 
interpreted as risk factors.  65 
 66 
To date, reviews exploring PSSP have either been narrative in nature18 or have 67 
focussed on factors that are correlated with PSSP.19 Whilst these give an indication 68 
of factors closely linked to PSSP, they are limited by the variations in methodologies 69 
included and do not give a satisfactory answer to the matter of risk.  70 
 71 
There is, therefore, a need to collate those studies investigating specifically risk and 72 
predictive factors that are effectively assessed and quantified using robust 73 
5 
 
prospective studies to see if there is agreement within the literature. The aim of this 74 
systematic review was to identify the potential risk factors measured within the first 75 





To complete and report this review the Preferred Reporting Items for Systematic 81 
Reviews and Meta-Analyses (PRISMA) statement20 was used. 82 
 83 
Search Strategy 84 
The search strategy was designed with the aid of a clinical librarian with input from 85 
the two lead authors (RH/KM). The databases AMED (1985 – April 2019), CINAHL 86 
(1937 – April 2019), EMBASE (1974 – April 2019), Medline (1946 – April 2019), and 87 
PubMed were used with no limitations applied. Variants of ‘stroke’, ‘shoulder pain’, 88 
and ‘risk factors’ were used as keywords and combined in the search strategy. The 89 
full search strategy can be viewed on the International Prospective Register of 90 
Systematic Reviews (PROSPERO: CRD42018110406) where this systematic review 91 
was registered. Further articles were sourced by hand-searching through the 92 
reference lists of key articles. The websites www.clinicaltrials.gov and 93 
www.ukctg.nihr.ac.uk were regularly reviewed to check for any ongoing trials that 94 




Study Selection 97 
Studies were eligible for inclusion only if the following three criteria were present: a) 98 
they were prospective cohort studies, b) they measured any potential risk factor 99 
within the first month after stroke and c) they measured pain as a key outcome within 100 
one year after stroke. Any definition and measure of pain used by study authors was 101 
deemed acceptable for inclusion. Studies in languages other than English were 102 
included only if a full-text English version could be sourced. To answer the specific 103 
question of risk it was felt essential that there was an element of temporality between 104 
the measurement of the risk factor and the measurement of pain, consequently 105 
correlates of PSSP were beyond the scope of this study. Studies were therefore 106 
excluded if they were cross-sectional studies in which all measures were taken at a 107 
single time-point (thereby assessing correlation rather than risk). Case reports, 108 
conference abstracts, poster presentations or other studies where the full report was 109 
not available were also excluded. 110 
 111 
Two reviewers (RH and KM) screened the titles and abstracts independently. Full-112 
text versions of the selected papers were obtained and were assessed against the 113 
inclusion and exclusion criteria by the same reviewers, again independently. Where 114 
there was disagreement a consensus was made through discussion along with the 115 




Authors were contacted when articles were lacking sufficient detail to assess the 118 
inclusion criteria. In all cases clarity was sought to understand if baseline measures 119 
were recorded within the first month after stroke. Authors were asked at what point 120 
baseline measures were taken and, to avoid bias, were not given information of the 121 
research question or the inclusion criteria.  122 
 123 
Data extraction & risk of bias assessment 124 
The main data extracted included all factors that were identified and analysed as 125 
potential risks or where sufficient data were supplied for factors where an odds ratio 126 
(OR) could be calculated. Other data extracted included the aims and methodology 127 
of each study, the period of observation, baseline characteristics of the cohort, 128 
inclusion/exclusion criteria, how pain was defined and measured, the temporal 129 
aspect of baseline and repeated measures, and limitations of the study in relation to 130 
the research question. 131 
 132 
The risk of bias of included studies was independently assessed by two reviewers 133 
(RH and KM) using the Quality in Prognosis Studies (QUIPS) tool.21 This tool 134 
considers six domains (Study Participation, Study Attrition, Prognostic Factor 135 
Measurement, Outcome Measurement, Study Confounding, and Statistical Analysis 136 
and Reporting) and rates these as having low, moderate or high risk of bias. Any 137 
disagreement between reviewers related to these assessments was resolved 138 




The overall risk of bias was determined a priori and judged as: low if 4 or more of the 141 
domains were rated low and no domains rated as high, moderate if 4 or less 142 
domains were rated low with one domain rated as high or 3 or less domains rated as 143 
low with no high risk domains, and high if 2 or more domains were rated as high or if 144 
1 domain was rated as high with no low risk domains. 145 
 146 
Data Synthesis 147 
The articles were described and summarised in a narrative form. Where possible, 148 
raw data were extracted from the original papers to calculate ORs and 95% 149 
confidence intervals (CI) with the intention of pooling these outcomes in meta-150 
analysis. Where raw data were not available the ORs presented in the original 151 
articles were used. 152 
 153 
Attempts were made to perform meta-analysis when data for a dichotomous variable 154 
were presented in three or more studies. Between-study heterogeneity was 155 
evaluated at face value based on methodological characteristics such as inclusion 156 
criteria and the method of outcome measurement. If there was substantial variation 157 
in the methods used then data were interpreted narratively. When it was possible to 158 
combine data, heterogeneity was assessed using the I2 statistic, although it is 159 
acknowledged that detecting true heterogeneity with a very small number of studies 160 




All analyses were performed using random effects models to account for the varied 163 
approaches within the studies. Funnel plots to assess for publication bias were not 164 
presented as it was felt that the small number of studies included would limit their 165 
usefulness of this analysis. All analyses were undertaken using the software 166 




Literature Search 171 
The search from the selected databases returned a total of 1,077 articles (figure 1). 172 
An additional 31 articles were sourced through hand-searching reference lists from 173 
key articles (n=3) and through search alerts following the initial search (n=28). During 174 
screening 593 were excluded as they clearly did not meet the necessary inclusion 175 
criteria. A further 11 abstracts were discarded as they were found to be poster 176 
presentations or conference abstracts, and one final paper published in Spanish23 177 
was excluded as it was not possible to access in English. 178 
 179 
The full text of the remaining 30 articles were assessed in more detail. A further 21 180 
were excluded due to (a) risk factors not been measured within the first month after 181 
stroke,8,17,24-30 (b) exploring factors correlated with PSSP rather than risk,15,16,31-36 (c) 182 
retrospective methodologies,37,38 and (d) studies’ aims not exploring risk of 183 
PSSP.39,40 Authors of four articles were contacted to seek further clarification 184 
regarding the timing of baseline measures. For two of these studies41,42 the authors 185 
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were able to confirm that the baseline measures were recorded within the first month 186 
and were included in the review. Of the other two, one author was unable to recall17 187 
and one author did not respond.8 These were therefore excluded. 188 
 189 
Figure 1. PRISMA Flow diagram of study selection 190 
<insert Figure 1> 191 
 192 
The remaining nine2,3,41-47 articles were included in the systematic review. Of these, 193 
seven provided sufficient data to calculate ORs on the four risk factors that had 194 
sufficient data to conduct meta-analyses. However, the study by Isaksson et al43 was 195 
excluded from all meta-analyses as it was thought to be too heterogeneous due to 196 
only including patients with pronounced UL weakness. It was felt that this was a 197 
significant difference from the populations of the other studies and was likely to 198 
significantly skew the analysis. 199 
 200 
Characteristics of included studies 201 
The nine papers included consisted of eight prospective cohort studies from seven 202 
different countries published between 200344 and 2018.41 A summary of the 203 
characteristics of the included studies is presented in table 1. The mean sample size 204 
of the studies was 309 (range: 31-1474). In total 2474 patients were included in the 205 
data synthesis consisting of 1237 (50%) males and 1237 (50%) females. It was not 206 
possible to calculate a combined description of participants’ age due to the variation 207 
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in descriptive statistics provided across studies. Three studies2,3,45 reported types of 208 
stroke and found that 87% (n=566) patients had an ischaemic stroke. Side of stroke 209 
was reported in four studies3,45-47; 54% (n=247) of participants having a left 210 
hemispheric stroke and 46% (n=211) having a right hemispheric stroke. 211 
 212 
Table 1. Characteristics of included studies 213 
<insert Table 1> 214 
 215 
Three papers2,3,44 included all stroke patients and took steps to ensure that 216 
participants with communication or cognitive impairments were included by involving 217 
carers or next-of-kin. One paper43 restricted participants to only those with 218 
pronounced arm weakness limiting the comparability with other studies. Another47 219 
explored only patients who had persistent PSSP leading to the loss of two patients 220 
who had pain but were excluded from the final analysis. 221 
 222 
Five studies2,3,44,46,47 presented prevalence rates or provided sufficient data to 223 
calculate a rate for PSSP at specific time points. Two studies did not present clear 224 
enough data to calculate a true prevalence, and one study looked at a specific 225 
subsection of patients. At baseline (within the first week), data was available on 1672 226 
patients3,44 and gave a prevalence rate of 16%. This prevalence increased to 21% 227 
(103/483) at four months,2,3 24% (293/1235) at 6 months44,47 and 23% (105/453) at 228 




The nine papers presented data on a total of 54 different factors that were measured 231 
temporally to allow the calculation of risk. Within these, seven were categorised as 232 
Demographic factors, 13 as Co-morbidities, and 34 as Clinical assessments and 233 
measures (table 1). 234 
 235 
Pain Measurement 236 
There were large variations in how pain was defined and measured. Four papers 237 
defined pain as either at rest or during passive or active movement43,45-47 but none of 238 
these reported how the data was handled when conflicting results between ‘at rest’ 239 
and ‘on movement’ were found. Four papers did not specify how they defined 240 
PSSP,2,41,42,44 and a final paper defined PSSP as any subjective complaint in the 241 
hemiplegic shoulder.3 Six papers used either the Visual Analogue Scale2,3,41,42 or the 242 
Numeric Rating Scale45,47 but only two42,45 reported a cut-off value to signify who had 243 
and did not have pain. The other three studies43,44,46 simply reported whether pain 244 
was ‘present’ or ‘absent’ to group their cohorts. Four studies assessed for pain using 245 
only subjective reports,2,43-45 whilst the others combined clinical examination and 246 
history-taking to determine if pain was present. 247 
 248 
Risk of Bias 249 
The risk of bias was assessed using the QUIPS tool and the ratings for each 250 
individual domain can be seen in figure 2. The level of agreement between the two 251 
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assessors (RH and KM) was calculated using the weighted Cohen’s kappa statistic 252 
(weighted κ = 0.68) which corresponded to a substantial degree of agreement.48 253 
 254 
Using these domains and a priori determined criteria, two studies2,3 were judged to 255 
have an overall low risk of bias, five studies to be moderate risk of bias,42-45,47 and 256 
two studies41,46 to have a high risk of bias overall.  257 
 258 
Figure 2. Assessment of risk of bias using the Quality in Prognosis Studies tool 259 
<insert Figure 2> 260 
 261 
Meta-analysis 262 
Only four factors had sufficient data to enable meta-analysis. All analyses were 263 
conducted using a random effects model to account for variations in the approaches 264 
used and samples taken. 265 
 266 
Five studies were included in the analysis of sex. Meta-analysis showed that there 267 
was no difference in the odds for men and women developing PSSP (OR 0.93, CI 268 
95% 0.75-1.15, p=0.501) (figure 3). The I2 statistic was very low (0.13%) suggesting 269 
heterogeneity was not present. However, Kontopantelis et al22 suggest caution when 270 
I2 is so low as it is likely that heterogeneity is present but undetected. Indeed the 271 





Four studies were included in the analysis of stroke laterality. Again no statistical 275 
difference was found in relation to whether the stroke was in the right or left 276 
hemisphere (OR 0.78, CI 95% 0.59-1.05, p=0.097, I2=9.52%) (figure 4). 277 
Interestingly, although not statistically significant, there is a shift of the 95% CI 278 
towards patients with right hemisphere strokes having a slightly increased risk of 279 
PSSP. Further studies would be needed to explore this. 280 
 281 
Figure 3. Forest plot displaying the pooled OR analysis for sex  282 
<insert Figure 3> 283 
 284 
Figure 4. Forest plot displaying the pooled OR analysis for laterality  285 
<insert Figure 4> 286 
 287 
The analysis for diabetes included six studies. Meta-analysis showed that diabetic 288 
patients were twice as likely to develop PSSP as patients without diabetes (OR 2.09, 289 
95% CI 1.16-3.78) and that this finding was statistically significant (p=0.015). 290 
However, there was a high degree of statistical heterogeneity (I2=74.15%) as can be 291 




Only three studies were available to conduct a meta-analysis for history of shoulder 294 
pain thereby limiting the acceptability of the results. The analysis identified that a 295 
history of shoulder pain increased the risk of developing PSSP (OR 2.78, 95% CI 296 
1.29-5.97) which was significant (p=0.009). Again, as can be seen in figure 6, there 297 
was a high level of heterogeneity between studies although an I2 statistic was not 298 
calculated as it was felt displaying this with the small number of included studies 299 
would provide misleading or inaccurate information. It is also worth noting that two 300 
studies with data were excluded from analysis due to significant variations in their 301 
inclusion criteria. Isaksson et al43 only included patients with pronounced weakness, 302 
and Roosink et al47 excluded patients with severe pre-morbid pain. Notably both of 303 
these studies showed non-significant results (table 3). 304 
 305 
All other factors were not appropriate for combining in meta-analysis and are 306 
summarised in narrative synthesis below. 307 
 308 
Figure 5. Forest plot displaying the pooled OR analysis for diabetes  309 
<insert Figure 5> 310 
 311 
Figure 6. Forest plot displaying the pooled OR analysis for history of shoulder pain 312 





The data for demographic data can be viewed in table 2. Analyses for age as a risk 316 
factor were inconclusive due the variations in measurement used. One study45 317 
reported an increased risk for younger patients (<70 years). However, two other 318 
studies3,44 found age to be nonsignificant as a predictor of PSSP when used as a 319 
factor in multivariate analysis. 320 
 321 
Four papers reported data on the type of stroke. Isaksson et al43 reported data that 322 
showed patients with haemorrhagic strokes were more likely to develop PSSP, 323 
however only patients with pronounced weakness were included which could bias 324 
the result. The other three studies2,3,45 showed no significant difference between 325 
types of stroke as a predictor. 326 
 327 
It was possible to calculate ORs for the subtype of stroke (Oxfordshire classification) 328 
in two papers.2,3 Only the total anterior circulation stroke was shown to be a 329 
significant risk for developing PSSP at four months when compared with lacunar 330 
stokes. 331 
 332 
One paper42 considered smoking habits as a potential risk factor but data was not 333 
available to calculate an OR. 334 
 335 
Table 2. Demographics - Factors with sufficient data to calculate OR 336 





Diabetes and a history of shoulder pain has been discussed in the meta-analysis. Of 340 
the other co-morbidities with data available for ORs none showed a statistically 341 
significant increased odds of developing PSSP (table 3). Temporary 342 
unconsciousness at onset was considered as a risk factor in one paper42 but data 343 
was not available to calculate an OR.  344 
 345 
Table 3. Comorbidities - Factors with sufficient data to calculate OR 346 
<insert Table 3> 347 
 348 
Clinical assessments and measures 349 
The full list of measures and ORs for clinical assessment and measures can be seen 350 
in table 4. Severity of upper limb (UL) motor function was concluded to be a major 351 
risk factor in four papers.2,3,44,45 Unfortunately a variety of outcome measures was 352 
used making comparisons unfeasible. Significant results were found for the odds 353 
ratio of a poor score on item 5 on the National Institutes of Health Stroke Scale (≥3) 354 
for the development of pain within 6 months45 and within 1 year.3 This measure was 355 
also shown to be significant (p=0.03) in a logistic regression analysis by Lind et al2 356 




Kim et al45 also measured motor function using the Fugl-Meyer arm score and found 359 
those patients with lower motor function (a score of 20 or less) were statistically 360 
more likely to develop PSSP at 6 months post-stroke than those with higher scores. 361 
 362 
Ratnasabapathy et al44 reported an increasing risk of PSSP as UL motor deficit 363 
increased from mild to moderate to severe, suggesting a potential trend. However it 364 
is worth noting that these categories were subjective reports from study participants 365 
and not based on standardised measures. 366 
 367 
It was deemed inappropriate to combine the findings for UL motor function in a meta-368 
analysis due to the substantial heterogeneity in the method of measurement. 369 
However, an impairment in UL motor function at baseline consistently produced a 370 
significantly increased chance of developing PSSP leading to the conclusion that it 371 
was an important risk factor to be aware of. 372 
 373 
Adey-Wakeling et al3 considered a specific set of shoulder tests (namely the 374 
modified Neer’s test, passive hand-behind-neck, and passive external rotation 375 
compared with the unaffected limb) as originally described by Rajaratnam et al.36 376 
Despite finding that these tests were able to identify a higher frequency of PSSP 377 
than by patient-report, when included in a multivariate analysis the odds ratio was 378 
not significant. This was supported by 2 other studies45,47 who explored early 379 





Table 4. Clinical assessments and measures - Factors with sufficient data to 383 
calculate OR 384 
<insert Table 4> 385 
 386 
Aspects of somatosensory function including sensation to light touch, sensation to 387 
temperature, sharpness, proprioception, tactile inattention and tactile extinction were 388 
also explored. Only tactile extinction and proprioception were found to significantly 389 
increase the risk of developing PSSP. 390 
 391 
Kim et al45 presented data on various baseline radiological and sonographic findings 392 
(table 1). Readers are directed to the original article to see the full list of ORs for the 393 
factors explored as they are too extensive to be repeated here. Only tendinosis or 394 
tear of the supraspinatus tendon at baseline sonography was associated with PSSP 395 
onset within the first 6 months (OR 4.21, 95% CI 1.37-12.93). 396 
 397 
Data was available to calculate ORs for PSSP at baseline in 2 studies,3,44 and found 398 
conflicting results. Paci et al46 did not provide data to calculate an OR but did find 399 
pain at baseline to be significantly associated with pain at follow-up in their multiple 400 
regression analysis (p<0.001), though this was approximately 2 to 3 months after 401 




Across the included studies, it was possible to calculate ORs for a number of other 404 
baseline measures including motor impairment, stroke severity, spasticity in the UL, 405 
subluxation of the glenohumeral joint, dependency during gait, cognition, visual 406 
problems, and autonomic function (table 4). These factors were each reported in 407 
only one study and the majority showed no significant relationship to the onset of 408 
PSSP. Only motor impairment (measured using the Motricity Index) and subluxation 409 
showed significant results though the wide 95% CIs for these results would bring into 410 
question the precision of this result.  411 
 412 
Anxiety, depression, communication disorders, and motivation for rehabilitation were 413 




This systematic review has identified reduced motor function in the UL, diabetes, and 418 
a history of shoulder pain as risk factors for the development of PSSP within the first 419 
year after stroke. It has also identified a number of clinical assessments made in the 420 
acute stages of stroke that were statistically significant but were only measured in 421 
single studies and lack the benefit of confirmatory evidence. These factors were 422 





The results presented should be interpreted with caution. Care was taken to limit 426 
bias as much as possible by only including prospective studies and by undertaking a 427 
complete and thorough literature search. However, meta-analyses of observational 428 
studies are prone to the biases inherent in the original studies,49 and unfortunately, 429 
the majority of studies included in this review were rated as a moderate or high risk 430 
of bias. Because of this potential bias, as much of the raw data as was feasible was 431 
included to increase transparency. This was also done so that the reader could make 432 
their own conclusions regarding the weighting each study had on the level of risk for 433 
each factor.   434 
 435 
The likelihood that reduced motor function in the UL leads to an increased risk of 436 
PSSP is unsurprising. The loss of motor function will undoubtedly alter the kinetics 437 
and kinematics around the shoulder complex. This suboptimal performance of 438 
scapula kinesis and the reduced control of forces around the humeral head on the 439 
glenoid has the potential to lead to deleterious effects on anatomical structures 440 
around the shoulder.50 Indeed, Idowu et al51 found a significantly higher frequency of 441 
shoulder pathologies in hemiplegic shoulders when compared with unaffected 442 
shoulders and control subjects, whilst Yi et al52 found a trend towards a higher 443 
prevalence of rotator cuff tears with worsening hemiplegia. Unfortunately, neither of 444 
these studies correlated these sonographic findings with the incidence of pain. 445 
 446 
A more recent prospective study53 of 121 participants further confirmed the 447 
association of reduced motor function of the UL as a risk factor for PSSP. They also 448 
concluded, in support of Paci et al,46 that subluxation was an important risk factor 449 
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and reported a significant proportional difference between those with subluxation 450 
who did and did not have PSSP at the 8-10 week follow up (p=0.026). However, 451 
when the data are used to calculate an OR in the same method as this review the 452 
outcome is non-significant (OR 1.68, 95% CI 0.49-5.70). It would seem logical that 453 
subluxation of the glenohumeral joint would lead to similar pathobiomechanics as 454 
previously discussed and thereby also be a risk factor for PSSP. However, further 455 
confirmatory studies with a temporal element to the measurement of risk factors and 456 
pain are required to clarify this. 457 
 458 
The identification of diabetes as a risk factor for PSSP is also unsurprising given the 459 
increased prevalence of shoulder pain in diabetic patients in the general 460 
population.50 Both tendinopathy51 and adhesive capsulitis52 were found to be more 461 
prevalent in patients with diabetes and both of these conditions are a potential 462 
source of PSSP. The increased risk of shoulder pain in diabetic patients is thought to 463 
be due to advanced glycation end-products causing stiffness and weakness in 464 
connective tissues,53 this, coupled with the reduced function following a stroke, may 465 
further enhance the damaging effects of structures in the shoulder complex. 466 
 467 
This exploratory review has identified a number of factors from the best available 468 
evidence that may aid clinicians in the early identification of patients who may 469 
develop PSSP. Based on these results it is advised that clinicians ensure they 470 
routinely enquire about diabetes and any history of shoulder pain when taking a 471 
patient’s medical history. It is not recommended that these findings should be 472 
construed as definitive due to the limitations mentioned hereinafter, however they 473 
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should be used as a guide to aid clinical reasoning and decision-making when 474 
deciding on which patients to focus preventative strategies. Knowledge of these risk 475 
factors may aid in the understanding of causation and thereby lead to more targeted 476 
prevention strategies. They will also provide clinicians with prognostic information to 477 
better inform patients, carers and relatives. 478 
 479 
Study Limitations  480 
There were a number of limitations within this systematic review that will impact on 481 
the validity of these results. These limitations were to be expected given the complex 482 
nature of PSSP observed in a clinical setting. Firstly, there were large variations in 483 
the included studies with regards to how pain was defined, how and when risk 484 
factors were measured, and how data were analysed. This has made comparability 485 
between studies very challenging and whilst some data have been combined in 486 
meta-analysis the results should be viewed as informative rather than definitive due 487 
to the heterogeneous nature of the studies included. 488 
 489 
Secondly, due to the large number of potential factors measured, the included 490 
studies may have been limited in what could feasibly be reported, potentially causing 491 
under-reporting or selective reporting of certain variables. Attempts were made to 492 
overcome this potential bias by calculating ORs for all factors where possible, 493 
thereby allowing the recognition of certain risk factors not reported or considered in 494 
the original studies. Whilst calculating crude ORs in this way allowed a larger pool of 495 
data it is recognised that univariate analysis of this type does not take into account 496 
the impact these different factors have on each other thereby potentially leading to 497 





The current categorisation of PSSP within the literature presents a potential problem. 501 
Whilst it is well documented that PSSP is complex and multifactorial in nature it is 502 
often referred to as a single entity rather than as an umbrella-term for a number of 503 
different aetiologies. This broad definition of PSSP is potentially limiting the 504 
specificity of research trials leading to conflicting results. It is recommended that 505 
future studies should explore improved classification of PSSP subtypes to allow 506 
more accurate links to be made between risk factors and PSSP presentation. 507 
 508 
It is also recommended that future studies exploring risk have a standardised and 509 
comparable approach to the measurement of pain. Whilst it is acknowledged that the 510 
measurement of pain in stroke patients presents some difficulties with regards to 511 
validity and reliability,58 a vertical numeric rating scale would be the preferred option. 512 
It is also recommended that data for pain at rest and on passive or active movement 513 
is analysed and reported separately to improve comparability. Studies exploring 514 
factors associated with PSSP should also give consideration to, and report on, any 515 
qualitative differences in the nature and pattern of pain between subjects, as well as 516 
factors such as whether the pain was at night or on clinical assessment only. 517 
Observational studies of this nature may help to better understand PSSP subtypes 518 
and improve specificity. Where possible, efforts should be made to ensure the 519 
inclusion of patients with communication or cognitive difficulties by using carers as 520 




Motor impairment of the upper limb was repeatedly shown to increase the risk of 523 
PSSP, however it was not possible to combine in meta-analysis due to variation in 524 
measurement. This important factor warrants further investigation. In this review the 525 
Fugl-Meyer Assessment was the most credible of the outcome measures used and 526 





This review has identified motor deficits in the UL, diabetes and a history of shoulder 532 
pain to be significant predictors of the development of PSSP within the first year after 533 
stroke. Whilst it is acknowledged that the lack of robust studies included prevent 534 
definitive conclusions to be made, it is hoped that the results presented will provide 535 
clinicians with a potential ‘at risk’ group of patients in the acute stage of stroke on 536 
whom to focus preventative strategies. A number of recommendations to standardise 537 
future studies in this area have been made. Future observational studies defining 538 
and categorising the subtypes of PSSP would be beneficial to aid research into the 539 
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Table 1. Characteristics
Table 1. Characteristics of included studies (cont.) 
 




Italy To study the 
relationship of shoulder 
subluxation w ith PSSP 
and functional 
recovery w ithin the 
f irst 3 months after 
stroke
107 Mean (SD)
71.3 (10.5) in 
subluxed 
group





First-ever stroke patients w here 
baseline measures taken w ithin 30 
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Excluded patients w ith severe, 
aphashia, severe cognitive 
impairment, history of shoulder 
pain/damage and w here the 
diagnosis of subluxation w as unclear
‒ Age
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‒ Laterality of stroke









New  Zealand Examine PSSP 
prevalence and factors 
associated w ith its 
occurrence in the f irst 







All strokes included ‒ Age
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associated w ith 
persistent PSSP in the 
f irst 6 months after 
stroke
31 Mean (SD)
72 (10) in 
persistent pain 
group




All f irst-ever, cortical or sub-cortical 
unilateral strokes resulting in senory 
and/or motor symptoms w ere eligible 
Excluded large amount of patients 
w ith comorbidities that could 
influence pain, premorbid arm pain, 
unable to adequately respond to 
closed questions, discharged w ithin 
f irst 3 days after stroke
‒ Age
‒ Sex
‒ Laterality of stroke 
‒ Handedness






‒ History of shoulder pain
‒ Motor function
‒ Reduced range of movement
‒ Spasticity of elbow  flexors
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Country Study Aims Sample 
size
Age Sex Eligibility criteria Risk factors explored: Time points for follow -
up assessments
Table 2. Demographics - Factors with sufficient data to calculate OR 
 








  OR (95% CI) 




1201 6 10 year increments 
 
1.08 (0.99-1.18)44 
  94 within 6 <70, 70 >   0.27 (0.09-0.80)45 
Sex (female) 31 6   0.29 (0.06-1.47)
47 
 
327 4   0.82 (0.48-1.41)
2 
 
1201 6   0.91 (0.69-1.19)
44 
 
226 within 12   1.03 (0.77-1.37)
3 
  94 within 6     1.56 (0.69-3.54)45 
Type of stroke  327 4 Imaging 
 
0.75 (0.30-1.89)2 




226 within 12 
  
1.07 (0.39-2.91)3 
  63 not stated     6.25 (1.1-35.6)43 
Stroke subtype 226 within 12 Oxfordshire  LACS  Reference 
  




















PACS  0.64 (0.32-1.29)2 
    
  
  TACS  5.19 (2.34-11.51)2 
Laterality  63 not stated Imaging 
 
0.51 (0.17-1.48)43 











Handedness (right) 31 6 Subjective report   1.26 (0.11-14.05)47 
Abbreviations: LACS, lacunar syndrome; POCS, posterior circulation syndrome; PACS, partial anterior circulation 
syndrome; TACS, total anterior circulation syndrome. 
 
Table 2. Demographics
Table 3. Comorbidities - Factors with sufficient data to calculate OR 
 




Time of follow-up 
(months) 
OR (95% CI) 
Diabetes Mellitus 226 within 12 1.2 (0.62-2.30)3 
 
1201 6 1.52 (1.07-2.17)44 
 
327 4 1.81 (0.92-3.56)2 
 
31 6 8.00 (1.13-56.79)47 
  152 within 12 8.77 (3.72-20.65)41 
TIA 31 6 0.29 (0.01-6.27)47 
Previous stroke 63 not stated 0.42 (0.12-1.49)43 
 
26 within 12 0.47 (0.21-1.07)3 
Previous MI 226 within 12 1.16 (0.53-2.54)3 
Hypertension 31 6 0.18 (0.02-1.71)47 
 
94 within 6 0.87 (0.39-1.99)45 
  226 within 12 0.96 (0.50-2.54)3 
History of shoulder 327 4 1.47 (0.81-2.67)2 
pain 31 6 1.63 (0.27-9.98)47 
 
63 not stated 1.64 (0.56-4.74)43 
 
1201 6 2.43 (1.54-3.84)44 
 
226 within 12 8.09 (3.16-20.80)3 
Fall at onset 63 not stated 1.79 (0.61-5.21)43 
Obesity 31 6 1.25 (0.10-15.80)47 
COPD 31 6 0.56 (0.05-5.86)47 
Hyperlipidaemia 152 within 12 0.80 (0.35-1.83)41 
Hypertriglyceridaemia  152 within 12 1.39 (0.64-3.02)41 
Malignancy 94 within 6 0.48 (0.11-2.11)45 
Abbreviations; TIA, transient ischaemic attack; MI, myocardial infarction; COPD, 





Table 4. Clinical assessments and measures - Factors with sufficient data to calculate OR 
 
Risk factor (exposure group) 
Number of 
participants 




  OR (95% CI) 
Stroke severity 226 within 12 NIHSS   1.39 (0.78-2.49)3 
Arm motor function (reduced) 73 3 NIHSS (Question 5)  3.08 (1.29-7.38)45 
 58 6   3.67 (1.55-8.70)45 
 226 within 12   2.81 (1.40-5.61)3 
 73 3 Fugl-Meyer arm  2.72 (1.14-6.49)45 
  58 6 score   3.59 (1.52-8.45)45 
Motor function (reduced) 31 6 Motricity index   25.00 (2.27-275.71)47 
Sensorimotor impairment 1201 6 Subjective report None Reference 
    Mild 2.44 (1.73-3.45)44 
    Moderate 3.72 (2.38-5.82)44 
        Severe 6.25 (4.15-9.43)44 
Motor evoked potential (no response) 73 3 EMG  4.09 (1.34-12.40)45 
58 6     2.20 (0.84-5.76)45 
Sensation (abnormal light touch) 73 3 NS  1.55 (0.66-3.61)45 
 58 6   1.18 (0.52-2.66)45 
  31 6 Cotton wool   1.67 (0.35-8.04)47 
Senation (abnormal cold sensation)  31 6 Metal tuning fork   2.67 (0.52-13.70)47 
Sensation (abnormal sharp sensation) 31 6 S-W filament   6.00 (0.63-57.00)47 
Proprioception (impaired) 31 6 Thumb JPS   6.4 (1.16-35.40)47 
Tactile inattention (impaired) 31 6 Uni- & bilateral stimuli   2.26 (0.04-123.00)47 
Tactile extinction (impaired) 31 6 Uni- & bilateral stimuli   7.60 (1.06-54.10)47 
Pain at baseline (present) 226 within 12 Subjective report  1.57 (0.29-8.45)3 
  1201 6     2.20 (1.61-3.01)44 
Spasticity (present) 73 3 Modified Ashworth   0.86 (0.27-2.77)45 
  58 6 Scale   2.79 (0.87-8.92)45 
ADLs (reduced) 73 3 Barthel index  1.40 (0.59-3.34)45 
  58 6     1.28 (0.56-2.94)45 
Shoulder assessment tests (positive) 226 within 12 Neer's test, PHBN, PER 2.10 (0.54-8.35)3 
Table 4. Clinical
ROM (reduced) 73 3 Goniometry  1.75 (0.75-4.09)45 
 58 6   1.29 (0.57-2.92)45 
  31 6 NS   6.00 (0.47-76.70)47 
Subluxation (present) 107 Approx 2-3 Palpation   28.93 (10.11-82.71)46 
Gait (immobile) 63 Approx 1-2 FAC   2.11 (0.22-20.12)43 
Cognition (impaired) 31 6 MMSE   2.71 (0.31-23.1)47 
Visual field (impaired) 31 6 Uni- & bilateral stimuli   2.71 (0.31-23.10)47 
Visual extinction (impaired) 31 6 Uni- & bilateral stimuli   3.00 (0.47-19.00)47 
Autonomic Dysfunction (present) 31 6 Trophic changes   3.40 (0.62-18.80)47 
Abbreviations: NIHSS, National Institutes of Health Stroke Scale; EMG, electromyography; NS, not stated; S-W, Semmes-Weinstein; 
JPS, joint position sense; ADLs, activities of daily living; PHBN, passive hand-behind-neck; PER, passive external rotation; ROM, range of 
movement; FAC, Functional Ambulation Classification; MMSE, Mini-Mental State Examination. 
 
